Tizanidine HCl

Product NDC: 51655-741
11-digit product format: 516550741
Labeler code: 51655
Product ID: 51655-741_46f1a3d0-5675-69f0-e054-00144ff8d46c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Tizanidine HCl
Dosage form: TABLET
Route: ORAL
Labeler: Northwind Pharmaceuticals
Application: ANDA091283
Marketing category: ANDA
Marketing start: 2017-01-25
Marketing end: 0000-00-00
Substance: TIZANIDINE HYDROCHLORIDE
Active strength: 4 mg/1
Pharmacologic classes: Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51655-741-26	2026-01-02	C162847	48780-1	9d75b9d0-445c-f424-e053-dadaa90a57ce	46f1a3d0-5674-69f0-e054-00144ff8d46c
51655-741-26	2020-01-31	C162847	48780-1	9d75b9d0-445c-f424-e053-dadaa90a57ce	46f1a3d0-5674-69f0-e054-00144ff8d46c

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51655-741	TIZANIDINE HCL TABLET [NORTHWIND PHARMACEUTICALS]	1	Legacy NDC	20170126_46f1a3d0-5674-69f0-e054-00144ff8d46c.zip